Harbinger Medical Group, LLC – Trademark Portfolio
Entity Type: 16
Harbinger Medical Group, LLC holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 10 trademarks are registered and 3 are pending. Notable registered marks include HITCH, ARTACENT, AMNIOHEAL, ARTACENT AC, and ARTACLEANSE. The owner is based in lafayette, LA.
1819 w pinhook rd
Suite 109
lafayette, LA 70508
Showing of trademarks Trademarks
Trademark Classifications
Harbinger Medical Group, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Harbinger Medical Group, LLC have?
Harbinger Medical Group, LLC has 18 U.S. trademarks filed with the USPTO. Of these, 10 registered, 3 pending, 3 abandoned, 2 cancelled.
What trademark classes does Harbinger Medical Group, LLC file in?
Harbinger Medical Group, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 7 (Machinery). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Harbinger Medical Group, LLC's most well-known trademarks?
Harbinger Medical Group, LLC's registered trademark portfolio includes well-known marks such as HITCH, ARTACENT, AMNIOHEAL, ARTACENT AC, and ARTACLEANSE. These are among 10 currently registered trademarks in the portfolio.
What is Harbinger Medical Group, LLC's trademark registration success rate?
Harbinger Medical Group, LLC has a 67% trademark registration rate, with 10 out of 15 resolved applications resulting in successful registration. Currently, 3 applications are pending review.